Company Profile
Company Profile
Australian-Inspired Innovation in Microbiome Science
D&D Healthcare is an innovative biotechnology company founded in Brisbane, Australia, specialising in microbiome and probiotic health solutions. Guided by the natural principle of supporting microbial balance through beneficial bacteria, we leverage our proprietary strain library and scientific research platform to develop gentle, science-based, and targeted microbiome health solutions for global consumers.
Mission & Vision: To become an educator and industry leader in microbiome health innovation, while upholding three core principles: every strain is grounded in scientific research; every product is developed under rigorous GMP quality standards; and every individual deserves access to trusted microbiome health support.
Double D Gene: The first “D” represents Dad (Protection), providing steadfast and warm long-term care and protection. The second “D” represents Dieticians & Doctors (Professionalism), integrating dietary intervention with rigorous medical logic to support internal health and wellbeing.
Technology Breakthroughs
Key Technology Breakthrough: Native Strain Screening
Pioneering stomach-derived native strains identified through high-throughput screening technology, enabling the precise selection of dual probiotic strains with strong human compatibility and gastrointestinal adaptability.
LRX-01 Precision Strain
Isolated from healthy breastfed newborns, with excellent safety and intestinal resilience.
LPF-01 Core Strain
Screened from over 1,200 stomach-derived strains, demonstrating strong acid tolerance and natural gastric adaptability.
Source: CN114891675B — Lactobacillus plantarum LPF-01 and Its Applications; CN113832077B — Lactobacillus rhamnosus LRX-01 and Its Applications.
Invention Patents
Patent Portfolio: Establishing a Strong Technology Barrier
Committed to proprietary and independently controlled core technologies. The key probiotic strains used in the formulation are protected by officially granted CNIPA invention patents, reinforcing both technological differentiation and commercial competitiveness.
LPF-01 Strain: Patented in China under “Gastric-Derived Lactobacillus plantarum LPF-01 and Its Applications” (ZL 2022 1 0515631.1).
LRX-01 Strain: Patented in China under “Lactobacillus rhamnosus and Its Applications” (ZL 2021 1 1290310.8).
L. reuteri HI120: Patented in China under “Lactobacillus reuteri HI120 and Its Applications” (Patent No. ZL 201711415835.3).
D&D-007 (Pipeline): An advanced probiotic strain designed to support healthy body rhythm and blood pressure balance.
Source: National Intellectual Property Administration, “Invention Patent Certificate” (Certificate No. 5603762 / 5956709).
Development Trends
Future Vision — From Microbiome Accessibility to Advanced Healthcare Integration
-
- 1、 Position GastricHealth as a leading gastrointestinal microbiome support product.2、 Deploy microfluidic H. pylori targeted assessment services to establish an integrated commercial ecosystem
Phase 1：Strategic Focus -
- With over 620 million people affected by H. pylori in China, D&D is committed to expanding access to advanced microbiome technologies and supporting earlier-stage gastrointestinal health management at population scale.
Phase 2: Technology Accessibility -
- Extend into mood and sleep support categories through the scientific framework of the gut–brain axis, reflecting a research-driven expansion strategy grounded in microbiome science.
Phase 3：Gut-Brain Axis Expansion -
- Leveraging proprietary strain libraries and ongoing evidence-based research, D&D aims to advance the integration of microbiome technologies into future healthcare and precision wellness applications.
Phase 4：Clinical Advancement
-
Phase 1：Strategic Focus
- 1、 Position GastricHealth as a leading gastrointestinal microbiome support product.2、 Deploy microfluidic H. pylori targeted assessment services to establish an integrated commercial ecosystem
-
Phase 2: Technology Accessibility
- With over 620 million people affected by H. pylori in China, D&D is committed to expanding access to advanced microbiome technologies and supporting earlier-stage gastrointestinal health management at population scale.
-
Phase 3：Gut-Brain Axis Expansion
- Extend into mood and sleep support categories through the scientific framework of the gut–brain axis, reflecting a research-driven expansion strategy grounded in microbiome science.
-
Phase 4：Clinical Advancement
- Leveraging proprietary strain libraries and ongoing evidence-based research, D&D aims to advance the integration of microbiome technologies into future healthcare and precision wellness applications.
Email: info@ddhealthcare.com.au
Tel: 020-37289759
Address: Room 01, 405B, Block A, Science and Technology Park, Guangdong University of Technology, No.131 Xianlie East Road, Tianhe District, Guangzhou
JD Flagship Store
Tmall Flagship Store
Email: info@ddhealthcare.com.au
Tel：020-37289759
Address: Room 01, 405B, Block A, Science and Technology Park, Guangdong University of Technology, No.131 Xianlie East Road, Tianhe District, Guangzhou
Website：https://www.ddhealthcare.com.au
JD Flagship Store
Tmall Flagship Store
点击右上角
分享给朋友吧
Copyright ©2023 All Rights Reserved D&D Healthcare sitemap
